Crystal Pharma

Crystal Pharma is a specialized developer and manufacturer of active pharmaceutical ingredients (APIs), with a primary focus on complex small molecules including steroids, hormones, and high-potency compounds (HPAPIs). Founded in 1996 and based in Valladolid, Spain, the company built a strong reputation for its expertise in fermentation, chemical synthesis, and sterile crystallization. In 2015, Crystal Pharma was acquired by AMRI (now Curia) for approximately $174 million, a move that integrated its high-end manufacturing capabilities into a global CDMO network. The company continues to operate as a vital production site for Curia, supporting the development and commercial supply of specialized APIs for global pharmaceutical markets. Its facilities are recognized for their high quality standards and ability to handle challenging chemistries and sterile requirements.